RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Bionano Genomics Stock

Bionano Genomics Equity 2025

Bionano Genomics Equity

35.38 M USD

Ticker

BNGO

ISIN

US09075F4046

WKN

A2JRLZ

In 2025, Bionano Genomics's equity was 35.38 M USD, a -63.21% increase from the 96.16 M USD equity in the previous year.

Bionano Genomics Aktienanalyse

What does Bionano Genomics do?

Bionano Genomics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Bionano Genomics's Equity

Bionano Genomics's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Bionano Genomics's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Bionano Genomics's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Bionano Genomics's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Bionano Genomics’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Bionano Genomics stock

What is the equity of Bionano Genomics this year?

Bionano Genomics has equity of 35.38 M USD this year.

What was the equity of Bionano Genomics compared to the previous year?

The equity of Bionano Genomics has increased/decreased by -63.21% decreased compared to the previous year.

What impact does a high equity have on investors of Bionano Genomics?

A high equity is advantageous for investors of Bionano Genomics as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Bionano Genomics?

A low equity can be a risk for investors of Bionano Genomics, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Bionano Genomics affect the company?

An increase in equity of Bionano Genomics can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Bionano Genomics affect the company?

A reduction in equity of Bionano Genomics can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Bionano Genomics?

Some factors that can affect the equity of Bionano Genomics include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Bionano Genomics so important for investors?

The equity of Bionano Genomics is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Bionano Genomics take to change the equity?

To change equity, Bionano Genomics can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Bionano Genomics pay?

Over the past 12 months, Bionano Genomics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Bionano Genomics is expected to pay a dividend of 0 USD.

What is the dividend yield of Bionano Genomics?

The current dividend yield of Bionano Genomics is .

When does Bionano Genomics pay dividends?

Bionano Genomics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Bionano Genomics?

Bionano Genomics paid dividends every year for the past 0 years.

What is the dividend of Bionano Genomics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Bionano Genomics located?

Bionano Genomics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Bionano Genomics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Bionano Genomics from 9/26/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/26/2025.

When did Bionano Genomics pay the last dividend?

The last dividend was paid out on 9/26/2025.

What was the dividend of Bionano Genomics in the year 2024?

In the year 2024, Bionano Genomics distributed 0 USD as dividends.

In which currency does Bionano Genomics pay out the dividend?

The dividends of Bionano Genomics are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Bionano Genomics

Our stock analysis for Bionano Genomics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Bionano Genomics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.